Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma

6 Jun 2014

Abstract excerpt

MCAM/MUC18 is a cell adhesion molecule associated with higher incidence of relapse in melanoma. The purpose of our study was to evaluate its role as a promising disease biomarker of progression through sequential molecular MCAM/MUC18 RT-PCR assay on serial blood samples collected during the clinical follow-up of 175 melanoma patients in different American Joint Committee on Cancer (AJCC) stages. MCAM/MUC18...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Cell Adhesion Molecules Research
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24902661
DOI: 10.1007/s00403-014-1473-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanomaPMID 24902661Read ↗

Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.Semantic proximity Read ↗

MCAM expression facilitates melanoma-endothelial interactions and promotes metastatic disease progressionSemantic proximity Read ↗

The role of N-Cadherin, MCAM, and β3 integrin in melanoma progression, proliferation, migration and invasionSemantic proximity Read ↗

A Subset of Host B Lymphocytes Controls Melanoma Metastasis through a Melanoma Cell Adhesion Molecule/MUC18-Dependent Interaction: Evidence from Mice and HumansSemantic proximity Read ↗

Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.Semantic proximity Read ↗

Enforced Expression of MCAM/MUC18 Increases In vitro Motility and Invasiveness and In vivo Metastasis of Two Mouse Melanoma K1735 Sublines in a Syngeneic Mouse ModelSemantic proximity Read ↗

Molecular markers of circulating melanoma cells.Semantic proximity Read ↗

The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker.Semantic proximity Read ↗

Gene Regulation in Melanoma Progression by the AP‐2 Transcription FactorSemantic proximity Read ↗

The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.Semantic proximity Read ↗

Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cellsSemantic proximity Read ↗

Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion MoleculeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.